SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-23-007732
Filing Date
2023-03-14
Accepted
2023-03-14 09:21:57
Documents
81
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K clsd-20221231.htm   iXBRL 10-K 3466492
2 EX-10.29 clsd-ex10_29.htm EX-10 164012
3 EX-10.30 clsd-ex10_30.htm EX-10 74870
4 EX-23.1 clsd-ex23_1.htm EX-23 16593
5 EX-31.1 clsd-ex31_1.htm EX-31 18192
6 EX-31.2 clsd-ex31_2.htm EX-31 18155
7 EX-32.1 clsd-ex32_1.htm EX-32 12084
8 GRAPHIC img100207284_0.jpg GRAPHIC 44522
9 GRAPHIC img100207284_1.jpg GRAPHIC 470104
10 GRAPHIC img140580400_0.jpg GRAPHIC 35686
11 GRAPHIC img140580400_1.jpg GRAPHIC 46523
12 GRAPHIC img140580400_2.jpg GRAPHIC 93886
  Complete submission text file 0000950170-23-007732.txt   13018165

Data Files

Seq Description Document Type Size
13 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT clsd-20221231_cal.xml EX-101.CAL 45405
14 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT clsd-20221231.xsd EX-101.SCH 67207
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT clsd-20221231_pre.xml EX-101.PRE 420569
16 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT clsd-20221231_lab.xml EX-101.LAB 563072
17 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT clsd-20221231_def.xml EX-101.DEF 266827
75 EXTRACTED XBRL INSTANCE DOCUMENT clsd-20221231_htm.xml XML 2217401
Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005 678-270-3631
Clearside Biomedical, Inc. (Filer) CIK: 0001539029 (see all company filings)

IRS No.: 452437375 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37783 | Film No.: 23729359
SIC: 2834 Pharmaceutical Preparations